Veterinary Immunogenics

Veterinary Immunogenics is a specialized biotechnology company focused on the development and manufacture of equine-specific biological products and pharmaceuticals. Based in the United Kingdom, the company is best known for its production of hyperimmune plasma, marketed as Equiplas, which is used to treat Failure of Passive Transfer (FPT) and various infections in foals. Additionally, the company provides high-molecular-weight hyaluronic acid treatments, such as Hy-50, for the management of joint dysfunction and osteoarthritis in horses. Veterinary Immunogenics operates a licensed manufacturing facility that adheres to stringent veterinary medicine standards to ensure the safety and efficacy of its regenerative and immunological therapies.